Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses
Huib H Rabouw, Martijn A Langereis, Robert C M Knaap, Tim J Dalebout, Javier Canton, Isabel Sola, Luis Enjuanes, Peter J Bredenbeek, Marjolein Kikkert, Raoul J de Groot, Frank J M van Kuppeveld, Huib H Rabouw, Martijn A Langereis, Robert C M Knaap, Tim J Dalebout, Javier Canton, Isabel Sola, Luis Enjuanes, Peter J Bredenbeek, Marjolein Kikkert, Raoul J de Groot, Frank J M van Kuppeveld
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory infections that can be life-threatening. To establish an infection and spread, MERS-CoV, like most other viruses, must navigate through an intricate network of antiviral host responses. Besides the well-known type I interferon (IFN-α/β) response, the protein kinase R (PKR)-mediated stress response is being recognized as an important innate response pathway. Upon detecting viral dsRNA, PKR phosphorylates eIF2α, leading to the inhibition of cellular and viral translation and the formation of stress granules (SGs), which are increasingly recognized as platforms for antiviral signaling pathways. It is unknown whether cellular infection by MERS-CoV activates the stress response pathway or whether the virus has evolved strategies to suppress this infection-limiting pathway. Here, we show that cellular infection with MERS-CoV does not lead to the formation of SGs. By transiently expressing the MERS-CoV accessory proteins individually, we identified a role of protein 4a (p4a) in preventing activation of the stress response pathway. Expression of MERS-CoV p4a impeded dsRNA-mediated PKR activation, thereby rescuing translation inhibition and preventing SG formation. In contrast, p4a failed to suppress stress response pathway activation that is independent of PKR and dsRNA. MERS-CoV p4a is a dsRNA binding protein. Mutation of the dsRNA binding motif in p4a disrupted its PKR antagonistic activity. By inserting p4a in a picornavirus lacking its natural PKR antagonist, we showed that p4a exerts PKR antagonistic activity also under infection conditions. However, a recombinant MERS-CoV deficient in p4a expression still suppressed SG formation, indicating the expression of at least one other stress response antagonist. This virus also suppressed the dsRNA-independent stress response pathway. Thus, MERS-CoV interferes with antiviral stress responses using at least two different mechanisms, with p4a suppressing the PKR-dependent stress response pathway, probably by sequestering dsRNA. MERS-CoV p4a represents the first coronavirus stress response antagonist described.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Onomoto K, Jogi M, Yoo J-SS, Narita R, Morimoto S, Takemura A, et al. Critical Role of an Antiviral Stress Granule Containing RIG-I and PKR in Viral Detection and Innate Immunity. PLoS One. 2012;7: e43031 10.1371/journal.pone.0043031
- White JP, Lloyd RE. Regulation of stress granules in virus systems. Trends Microbiol. 2012;20: 175–83. 10.1016/j.tim.2012.02.001
- Wippich F, Bodenmiller B, Trajkovska MG, Wanka S, Aebersold R, Pelkmans L. Dual specificity kinase DYRK3 couples stress granule condensation/ dissolution to mTORC1 signaling. Cell. 2013;152: 791–805. 10.1016/j.cell.2013.01.033
- Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol. 2008;10: 1324–1332. 10.1038/ncb1791
- Kim WJ, Back SH, Kim V, Ryu I, Jang SK. Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol Cell Biol. 2005;25: 2450–2462. 10.1128/MCB.25.6.2450-2462.2005
- Lu Y, Wambach M, Katze MG, Krug RM. Binding of the Influenza Virus NS1 Protein to Double-Stranded RNA Inhibits the Activation of the Protein Kinase That Phosphorylates the eIF-2 Translation Initiation Factor. Virology. 1995;214: 222–228
- Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol. 2000;74: 7989–7996.
- Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol. 2007;81: 548–557. 10.1128/JVI.01782-06
- Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, et al. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe. 2012;11: 607–616. 10.1016/j.chom.2012.04.011
- Lorusso A, Decaro N, Schellen P, Rottier PJM, Buonavoglia C, Haijema B-J, et al. Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol. 2008;82: 10312–7. 10.1128/JVI.01031-08
- Haijema BJ, Volders H, Rottier PJM. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol. 2004;78: 3863–71. 10.1128/JVI.78.8.3863-3871.2004
- Liu DX, Fung TS, Chong KKL, Shukla A, Hilgenfeld R. Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Research. 2014. pp. 97–109.
- Herrewegh AAPM, Vennema H, Horzinek MC, Rottier PJM, de Groot RJ. The Molecular Genetics of Feline Coronaviruses: Comparitive Sequence Analysis of the ORF7a/7b Transcription Unit of Different Biotypes. Virology. 1995;212: 622–631. 10.1006/viro.1995.1520
- Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24: 1634–1643. 10.1038/sj.emboj.7600640
- WHO | Middle East respiratory syndrome coronavirus (MERS-CoV)–Saudi Arabia WHO. World Health Organization; 2016.
- Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM MT. Evidence for Camel-to-Human Transmission of MERS Coronavirus. New Engl J Med. 2014;370: 2499–2505. 10.1056/NEJMoa1401505
- Briese T, Mishra N, Jain K, East M, Syndrome R, Quasispecies C, et al. Dromedary Camels in Saudi Arabia Include Homologues of Human Isolates Revealed through Whole-Genome analysis etc. MBio. 2014;5: 1–5.
- Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M, et al. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol. 2013;87: 5300–4. 10.1128/JVI.03496-12
- Chan RWY, Chan MCW, Agnihothram S, Chan LLY, Kuok DIT, Fong JHM, et al. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol. 2013;87: 6604–14. 10.1128/JVI.00009-13
- Kindler E, Jónsdóttir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, et al. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio. 2013;4.
- Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, et al. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol. 2013;87: 12489–95. 10.1128/JVI.01845-13
- Siu K-L, Yeung ML, Kok K-H, Yuen K-S, Kew C, Lui P-Y, et al. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol. 2014;88: 4866–76. 10.1128/JVI.03649-13
- Yang Y, Zhang L, Geng H, Deng Y, Huang B, Guo Y, et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. 2013;4: 951–961. 10.1007/s13238-013-3096-8
- de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RWAL, et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J Gen Virol. 2013;94: 1749–1760. 10.1099/vir.0.052910-0
- Nejepinska J, Malik R, Moravec M, Svoboda P. Deep sequencing reveals complex spurious transcription from transiently transfected plasmids. PLoS One. 2012;7.
- Chang HW, Watson JC, Jacobs BL. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A. 1992;89: 4825–4829.
- Feng Z, Cerveny M, Yan Z, He B. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol. 2007;81: 182–192. 10.1128/JVI.01006-06
- McEwen E, Kedersha N, Song B, Scheuner D, Gilks N, Han A, et al. Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J Biol Chem. 2005;280: 16925–16933. 10.1074/jbc.M412882200
- Dang Y, Kedersha N, Low WK, Romo D, Gorospe M, Kaufman R, et al. Eukaryotic initiation factor 2α-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem. 2006;281: 32870–32878. 10.1074/jbc.M606149200
- Khaperskyy DA, Emara MM, Johnston BP, Anderson P, Hatchette TF, McCormick C. Influenza A Virus Host Shutoff Disables Antiviral Stress-Induced Translation Arrest. PLoS Pathog. 2014;10.
- Hato S V, Ricour C, Schulte BM, Lanke KHW, de Bruijni M, Zoll J, et al. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol. 2007;9: 2921–2930. 10.1111/j.1462-5822.2007.01006.x
- Feng Q, Langereis M a, Lork M, Nguyen M, Hato S V, Lanke K, et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol. 2014;88: 3369–78. 10.1128/JVI.02712-13
- Dubois MF, Hovanessian AG. Modified subcellular localization of interferon-induced p68 kinase during encephalomyocarditis virus infection. Virology. 1990;179: 591–598.
- Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, et al. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell. 2010;143: 225–37. 10.1016/j.cell.2010.09.026
- Siu K-L, Yeung ML, Kok K-H, Yuen K-S, Kew C, Lui P-Y, et al. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol. 2014;88: 4866–76. 10.1128/JVI.03649-13
- Yang Y, Ye F, Zhu N, Wang W, Deng Y, Zhao Z, et al. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep. Nature Publishing Group; 2015;5: 17554 10.1038/srep17554
- Lui P-Y, Wong L-YR, Fung C-L, Siu K-L, Yeung M-L, Yuen K-S, et al. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerg Microbes Infect. Nature Publishing Group; 2016;5: e39 10.1038/emi.2016.33
- Bailey-Elkin BA, Knaap RCM, Johnson GG, Dalebout TJ, Ninaber DK, Van Kasteren PB, et al. Crystal structure of the middle east respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem. 2014;289: 34667–34682. 10.1074/jbc.M114.609644
- de Haan CAM, Masters PS, Shen X, Weiss S, Rottier PJM. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology. 2002;296: 177–189. 10.1006/viro.2002.1412
- Lissenberg A, Vrolijk MM, van Vliet ALW, Langereis MA, de Groot-Mijnes JDF, Rottier PJM, et al. Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. J Virol. 2005;79: 15054–63. 10.1128/JVI.79.24.15054-15063.2005
- Herrewegh AAPM, De Groot RJ, Cepica A, Egberink HF, Horzinek MC, Rottier PJM. Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J Clin Microbiol. 1995;33: 684–689
- Koetzner CA, Kuo L, Goebel SJ, Dean AB, Parker MM, Masters PS. Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus. J Virol. 2010;84: 8262–8274. 10.1128/JVI.00385-10
- Kint J, Dickhout A, Kutter J, Maier HJ, Britton P, Koumans J, et al. Infectious bronchitis coronavirus inhibits STAT1 signalling and requires accessory proteins for resistance to type I interferon. J Virol. 2015; JVI.01057–15.
- Groot RJ De, Ziebuhr J, Poon LL, Woo PC, Rottier PJM, Holmes K V, et al. ICTV taxonomic assignation form Coronavirus 2008. Taxon Propos to ICTV Exec Comm. 2008; 1–37
- Wang X, Liao Y, Yap PL, Png KJ, Tam JP, Liu DX. Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells. J Virol. 2009;83: 12462–12472. 10.1128/JVI.01546-09
- Cruz JLG, Sola I, Becares M, Alberca B, Plana J, Enjuanes L, et al. Coronavirus gene 7 counteracts host defenses and modulates virus virulence. PLoS Pathog. 2011;7.
- Sola I, Galán C, Mateos-Gómez PA, Palacio L, Zúñiga S, Cruz JL, et al. The polypyrimidine tract-binding protein affects coronavirus RNA accumulation levels and relocalizes viral RNAs to novel cytoplasmic domains different from replication-transcription sites. J Virol. 2011;85: 5136–49. 10.1128/JVI.00195-11
- Raaben M, Groot Koerkamp MJA, Rottier PJM, de Haan CAM. Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies. Cell Microbiol. 2007;9: 2218–2229. 10.1111/j.1462-5822.2007.00951.x
- Bechill J, Chen Z, Brewer JW, Baker SC. Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. J Virol. 2008;82: 4492–4501. 10.1128/JVI.00017-08
- Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol. 2007;81: 2554–2563. 10.1128/JVI.01634-06
- Krähling V, Stein DA, Spiegel M, Weber F, Mühlberger E. Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J Virol. 2009;83: 2298–2309. 10.1128/JVI.01245-08
- de Wilde AH, Wannee KF, Scholte FE, Goeman JJ, Ten Dijke P, Snijder EJ, et al. A kinome-wide siRNA screen identifies proviral and antiviral host factors in SARS-coronavirus replication, including PKR and early secretory pathway proteins. J Virol. 2015;
- Corman VM, Kallies R, Philipps H, Göpner G, Müller MA, Eckerle I, et al. Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs. J Virol. 2014;88: 717–24. 10.1128/JVI.01600-13
- Woo PCY, Lau SKP, Li KSM, Poon RWS, Wong BHL, Tsoi H wah, et al. Molecular diversity of coronaviruses in bats. Virology. 2006;351: 180–187. 10.1016/j.virol.2006.02.041
- Woo PC, Lau SK, Li KS, Tsang AK, Yuen K-Y. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbes Infect. 2012;1: e35 10.1038/emi.2012.45
- Woo PCY, Wang M, Lau SKP, Xu H, Poon RWS, Guo R, et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol. 2007;81: 1574–1585. 10.1128/JVI.02182-06
- Lamers MM, Raj VS, Shafei M, Ali SS, Abdallh SM, Gazo M, et al. Deletion Variants of Middle East Respiratory Syndrome Coronavirus from Humans, Jordan, 2015. Emerg Infect Dis. 2016.
- Haijema B-J, Rottier PJ, De Groot RJ. Feline coronaviruses: a tale of two-faced types. Coronaviruses: molecular and cellular biology
- Vennema H, Poland A, Foley J, Pedersen NC. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology. 1998;243: 150–157. 10.1006/viro.1998.9045
- Min J, Yu D, Liang W, Xu R, Wang Z, Fang L, et al. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303: 1666–1669. 10.1126/science.1092002
- Corman VM, Eckerle I, Memish ZA, Liljander AM, Dijkman R, Jonsdottir H, et al. Link of a ubiquitous human coronavirus to dromedary camels. Proc Natl Acad Sci. 2016; 201604472.
- Zaki AM1, van Boheemen S, Bestebroer TM, Osterhaus AD FR. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. New Engl J Med. 2012;367: 1814–20. 10.1056/NEJMoa1211721
- Almazan F, DeDiego ML, Sola I, Zuniga S, Nieto-Torres JL, Marquez-Jurado S, et al. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio. 2013;4: e00650–13. 10.1128/mBio.00650-13
- Tischer BK, Von Einem J, Kaufer B, Osterrieder N. Two-step Red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques. 2006;40: 191–197.
- Duke GM, Palmenberg AC. Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts. J Virol. 1989;63: 1822–1826.
- Langereis MA, Rabouw HH, Holwerda MH, Visser LJ, van Kuppeveld FJM. Knockout of cGAS and STING Rescues Virus Infection of Plasmid DNA-transfected cells. J Virol. 2015;89: 11169–11173. 10.1128/JVI.01781-15
- Bordeleau M-E, Matthews J, Wojnar JM, Lindqvist L, Novac O, Jankowsky E, et al. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc Natl Acad Sci U S A. 2005;102: 10460–10465. 10.1073/pnas.0504249102
- Wessels E, Duijsings D, Notebaart RA, Melchers WJG, van Kuppeveld FJM, Melchers JG, et al. A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol. 2005;79: 5163–73. 10.1128/JVI.79.8.5163-5173.2005
- Langereis MA, Feng Q, van Kuppeveld FJ. MDA5 localizes to stress granules, but this localization is not required for the induction of type I interferon. J Virol. 2013;87: 6314–25. 10.1128/JVI.03213-12
Source: PubMed